PascalFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Neuroleptique »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neuroinflammation < Neuroleptique < Neurologie  Facettes :

List of bibliographic references indexed by Neuroleptique

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
001038 (2013) James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
001062 (2013) Philip Seeman [Canada] ; Michele Tinazzi [Italie]Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia
001541 (2012) Pierre J. Blanchet [Canada] ; Louise Normandeau [Canada] ; Pierre H. Rompre [Canada]Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study
001D45 (2010) Andrew R. Brown [Canada] ; BIN HU [Canada] ; Bryan Kolb [Canada] ; G. Campbell Teskey [Canada]Acoustic tone or medial geniculate stimulation cue training in the rat is associated with neocortical neuroplasticity and reduced akinesia under haloperidol challenge
002078 (2009) Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Maxime Levesque [Canada] ; Mark Chebli [Canada] ; Maxime Parent [Canada] ; Richard Courtemanche [Canada] ; Pierre J. Blanchet [Canada]Motor sequence learning in primate : Role of the D2 receptor in movement chunking during consolidation
002651 (2007) Michelle R. Ciucci [États-Unis] ; Sean T. Ma [États-Unis] ; Cynthia Fox [États-Unis] ; Jacqueline R. Kane [États-Unis] ; Lorraine O. Ramig [États-Unis] ; Timothy Schallert [États-Unis]Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol : A preliminary study
002B17 (2005) Guy Chouinard [Canada] ; Howard C. Margolese [Canada]Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
002B48 (2005) Brad Hagen [Canada] ; Chris Armstrong Esther [Canada] ; Roland Ikuto [Canada] ; Robert J. Williams [Canada] ; Carole-Lynne Le Navenec [Canada] ; Morgan AhoAntipsychotic drug use in Canadian long-term care facilities : prevalence, and patterns following resident relocation
003058 (2002) Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie]Role of serotonin2C receptors in the control of brain dopaminergic function
003351 (2001) Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover
003355 (2001) Daniel S. Sa [Canada] ; Shitij Kapur [Canada] ; Anthony E. Lang [Canada]Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis
003561 (2000) Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique]Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial
003C33 (1997) L. Thorpe [Canada]The treatment of psychotic disorders in late life
003E88 (1996) P. Sandor [Canada] ; A. E. Lang [Canada] ; S. Singal [Canada] ; C. Augus [Canada]Remoxipride in the treatment of levodopa-induced psychosis
004085 (1995) A. E. Lang [Canada] ; P. Sandor ; J. Duff [Canada]Remoxipride in Parkinson's disease : differential response in patients with dyskinesias fluctuations versus psychosis
004458 (1993) R. W. Lam [Canada]Chronic schizophrenia and idiopathic Parkinson's disease
004A04 (1990) E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. CalneClozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis
004B38 (1989) E. C. Wolters ; T. A. Hurwitz ; R. F. Peppard ; D. B. CalneClozapine: an antipsychotic agent in Parkinson's disease?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Neuroleptique" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Neuroleptique" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Neuroleptique
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022